Netherlands· NL-b69a0ac1bfd8

Strumazol 10 mg, tabletten

A thiamazole product containing thiamazol, registered in Netherlands by Euro Registratie Collectief B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC H03BB02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about thiamazolAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Thiamazole is registered in 12 of 19 countries.

Countries holding a registration under ATC H03BB02 (thiamazole), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search thiamazole products by name

Thiamazole · ATC H03BB02

12 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Netherlands
Polandprice
Sweden
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of thiamazole costs, country by country.

Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Thiamazole · price per daily dose (10 mg)

USD · FX 28 Sept 2026

FR France$0.12

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: THIAMAZOL
Manufacturer: Euro Registratie Collectief B.V.
Country: Netherlands (NL)
ATC code: H03BB02
ATC class: Thiamazole
Defined daily dose: 10 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
118688//02224

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

170 interactions on record for thiamazole.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check thiamazole against other medicines How interaction checks work

Thiamazole · interactions on record

170 records

10 severe
42 moderate
2 minor
116 info

Most severe, free to view

MipomersenC10AX11severe
LomitapideC10AX12severe
PexidartinibL01EX15severe
LeflunomidL04AA13severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Thiamazole in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All thiamazole products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

Austria · Thiamazol Sandoz
Belgium · Strumazol
Bulgaria · Метизол, Тирозол
Cyprus · Unimazole
Czechia · Thyrozol
Germany · Methizol Sd, Thiamazol
Denmark · Thiamazole "uni-Pharma", Thycapzol
Estonia · Thyrozol
Spain · Tirodril
France · Thiamazole Uni-Pharma, Thyrozol
Greece · Unimazole
Croatia · Athyrazol
Hungary · Metothyrin
Iceland · Thiamazole Uni-Pharma
Italy · Tapazole
Lithuania · Metizol, Thyrozol
Luxembourg · Strumazol, Thyrozol
Latvia · Thyrozol
Poland · Metizol, Thyrozol
Portugal · Metibasol
Romania · Thyrozol
Sweden · Thacapzol, Thiamazole Uni-Pharma
Slovenia · Athyrazol
Slovakia · Thyrozol

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/1caeb135-fb79-4bc1-8b66-137f6b9e579b
GET /v1/drugs/1caeb135-fb79-4bc1-8b66-137f6b9e579b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h02224_smpc.pdf",
  "strength": null,
  "atc_label": "Thiamazole",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg118688",
  "excipients": [
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD"
  ],
  "substances": [
    "THIAMAZOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h118688.pdf",
  "authorised_at": "2016/01/21",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "118688//02224",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about thiamazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console